A Novel Magneto-fluorescent Nano-bioprobe for Cancer Cell Targeting, Imaging and Collection.pdf
- 1、本文档共13页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
A Novel Magneto-fluorescent Nano-bioprobe for Cancer Cell Targeting, Imaging and Collection
A Novel Magneto-fluorescent Nano-bioprobe for Cancer
Cell Targeting, Imaging and Collection
Yicheng Wu Maoquan Chu Bizhi Shi Zonghai Li
Received: 1 June 2010 /Accepted: 7 September 2010 /
Published online: 16 October 2010
# Springer Science+Business Media, LLC 2010
Abstract Silica-coated magnetic polystyrene nanospheres (MPN) containing CdTe/CdS
quantum dots (QDs) and Fe3O4 nanoparticles were prepared, and novel anti-EGFR
antibodies were conjugated onto these magneto-fluorescent nanocomposites (MPN–QDs–
SiO2) for cancer cell targeting, imaging and collection. Transmission electron microscopy
(TEM), scanning electron microscopy (SEM) images and energy-dispersive x-ray
spectrometry (EDS) data showed that the MPN had been successfully coated with QDs
and a silica shell, and the nanocomposites obtained with negative charged surfaces were
well dispersed. The bioconjugates could be used for specifically labeling and separating
cancer cells (MDA-MB-435S, SMMC-7721), but did not recognize and separate the K562
cells because the human epidermal growth factor receptor (EGFR) was not expressed on the
surface. Because the anti-EGFR antibody, which we have developed, could specifically
recognize certain cancer cells that highly expressed EGFR on their surface, these nanoscale
bioconjugates, synchronously exhibiting fluorescence and magnetism, may be used in novel
bioprobes for labeling and collecting rare cancer cells, which may be beneficial for early
cancer diagnosis.
Appl Biochem Biotechnol (2011) 163:813–825
DOI 10.1007/s12010-010-9085-y
Y. Wu :M. Chu
School of Life Science and Technology, Tongji University, Shanghai 200092,
People’s Republic of China
M. Chu (*)
Institute for Advanced Materials and Nano Biomedicine, Tongji University, Shanghai 200092,
People’s Republic of China
e-mail: mqchu98@tongji.edu.cn
B. Shi : Z. Li
State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Shanghai,
People’s Republic of China
Z. Li (*)
School of Medicine, Shang
文档评论(0)